Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SII yellow fever vaccine versus STAMARIL in healthy infants
PACTR202206910703861Phase 3Recruiting
- Sponsor
- Serum Institute of India
- Start
- Jul 2022
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3 trial of 17D yellow fever vaccine in yellow fever (2 arms), sponsored by Serum Institute of India. Primary endpoint: Percentage seroconversion. Started Jul 2022; status: recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on PACTR202206910703861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202206910703861.